releases: https://www.cramer.senate.gov/sens-cramer-durbin-smith-applaud-inclusion-their-bill-lower-insulin-costs-todays-appropriations
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://www.cramer.senate.gov/sens-cramer-durbin-smith-applaud-inclusion-their-bill-lower-insulin-costs-todays-appropriations | Sens. Cramer, Durbin, Smith Applaud Inclusion of Their Bill to Lower Insulin Costs in Today's Appropriations Package | 2019-12-19 | 2019 | 2019-12 | Republican | House | ND | Kevin Cramer | C001096 | www.cramer.senate.gov | legacy | ***Click here for audio.*** WASHINGTON U.S. Senators Dick Durbin (D-IL), Kevin Cramer (R-ND), and Tina Smith (D-MN) today applauded the inclusion in the Fiscal Year (FY) 2020 appropriations bill of theirAffordable Insulin Approvals Now Act, a bipartisan bill to speed up approvals of lower-cost, generic insulin products in order to help reduce prices of this life-saving medication for patients. Approximately 7.5 million Americans with diabetes rely on insulin every day to survive, yet the drug has experienced a price increase of more than 600 percent over the past two decades in the United States. Increasing the amount of generic and low-cost insulin in the market will decrease the burden placed on patients who rely on these drugs,said Cramer.I am pleased to see our bipartisan bill included in this package, and I plan to keep working to find more ways to encourage competition and free market solutions to the rising cost of health care." Read the full release here. | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |